The Swiss Post is expanding its drone delivery system, transporting laboratory samples between two hospitals in Zurich. Similar pilots have been conducted in Bern and Lugano.
This content was published on
1 minute
Keystone SDA/sb
العربية
ar
البريد السويسري يوسّع دائرة استخدام نظام الطائرات من دون طيار
On Tuesday, the Swiss Post announced it is launching a one-year pilot project to use drones to send laboratory samples between the University Hospital of Zurich and the Irchel site of the University of Zurich, which are 2.5 kilometres apart. Laboratory samples will arrive at their destination twice as quickly by air as by road.
These time savings are expected to help patients, for example those under anesthesia waiting for laboratory results.
The first official flights are expected on Thursday, with five to ten flights per day scheduled on weekdays. The project is being carried out in collaboration with the Federal Office of Civil Aviation (FOCA), Skyguide, which monitors Swiss airspace, and the local authorities.
A similar pilot in Lugano began in March 2017 and has conducted 2,100 flights without any problems. In Bern, a two-week trial took place in June between the main laboratory of the InselSpital University Hospital and the Tiefenau Hospital. An evaluation is currently underway.
More
More
Post office to start drone tests in Lugano
This content was published on
Drones will be used this month to start delivering laboratory samples between two hospitals in canton Ticino as part of tests carried out by Swiss Post.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
This content was published on
The use of drones for disaster relief – whether to deliver cargo, map terrain or assess structural damage – is growing, but fraught with challenges.
This content was published on
The government has said that no favouritism is involved in the deal that will see Swiss Post delivering packages for retail giant Amazon.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.